FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device Approvals, Clinical Trials, Eye Surgery, FDA, Ophthalmic Surgery, Ophthalmics, R&D The U.S. Food and Drug Administration approved Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. Read more April 7, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-04-07 07:30:452021-04-07 12:18:34FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device
